Prevention of inflammatory diseases by regulating the production of lipid mediators-basic and clinical studies

通过调节脂质介质的产生预防炎症性疾病——基础和临床研究

基本信息

项目摘要

Inflammatory diseases include allergy, cancers of the Western type and many kinds of so-called intractable diseases. We interpreted that persistent inflammation is a major cause for the increased incidence of these diseases in Japan in the past half a century, and that these inflammatory diseases could be prevented by regulating the production of inflammatory mediators. At present, no safe means has been found to regulate the production of peptide mediators. However, the amounts and activities of lipid mediators can be modified safely by reducing the intake of n-6 fatty acids and increasing that of n-3 fatty acids in foods.In animal experiments, reducing the content of linoleic acid (n-6) and increasing that of α-linolenic acid (n-3) or fish oil enriched with EPA (n-3) and DHA (n-3) were shown to suppress the productions and activites of lipid kidney was suppressed similarly, and some results from animal experiments are collected in this report.On the other hand, we collaborated with clinicians to perform clinical trials aimed at treating atopic dermatitis and colorectal tumors by lowering the n-6/-3 ratio of fatty acids in foods. Subjects with atopic dermatitis (n=76) were advised to select foods so as to lower the n-6/n-3 ratio of ingested fatty acids, and were followed for 2 years to find that this means is very promising for the improvement of hyper-allergic constitution. In the randomized control trial for the suppression of recurrence of colorectal polyps after polypectomy, the number of subjects participating in the trial has been increasing. When the number of subjects was 20 in each group, this method seemed to be promising, too.These results support our interpretation that increased linoleic acid intake (>2.5 times high compared with the level of 40 years ago, several-fold higher than the essential amount) and relative n-3 fatty acid deficiency are the major causes for the increases in the incidence of these diseases.
炎症性疾病包括过敏,西方类型的癌症和许多所谓的顽固性疾病。我们解释说,在过去的半个世纪里,持续的炎症是日本这些疾病发病率增加的主要原因,这些炎症性疾病可以通过调节炎症介质的产生来预防。目前,还没有找到安全的方法来调节多肽介质的产生。然而,通过减少食物中n-6脂肪酸的摄入和增加n-3脂肪酸的摄入,可以安全地改变脂质介质的数量和活性。动物实验表明,降低亚油酸(n-6)含量,增加α-亚麻酸(n-3)含量,或富含EPA (n-3)和DHA (n-3)的鱼油均可抑制脂质肾的生成和活性,本报告收集了部分动物实验结果。另一方面,我们与临床医生合作,通过降低食物中n-6/-3脂肪酸的比例,进行治疗特应性皮炎和结直肠肿瘤的临床试验。建议76例特应性皮炎患者选择食物以降低摄入脂肪酸的n-6/n-3比率,并随访2年,发现这种方法对改善超过敏体质非常有希望。在抑制结直肠息肉切除术后复发的随机对照试验中,参与试验的受试者数量不断增加。当每组受试者人数为20人时,这种方法似乎也很有前途。这些结果支持了我们的解释,即亚油酸摄入量的增加(与40年前相比增加2.5倍,比必需量高出数倍)和n-3脂肪酸的相对缺乏是这些疾病发病率增加的主要原因。

项目成果

期刊论文数量(148)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tokudome, S., Imaeda, N., Tokudome, Y., Kuriki, K., Cheng, J., Fujii, T., Goto, C., Nagaya, T., Ichikawa, H., Okuyama, H.: "Correspondence re: Terry et al., No association between fat and fatty acid intake and risk of colorectal cancer."Cancer Epidemiol.B
德留 S.、今枝田 N.、德留 Y.、栗木 K.、程 J.、藤井 T.、后藤 C.、长谷 T.、市川 H.、奥山 H.:
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Miyazawa, D., Ikemoto, A., Fujii, Y., Okuyama, H.: "Partial purification and characterization of phosphatidic acid-specific phospholipase A1 in porcine platelet membranes."Biochim.Biophys.Acta.. 1631. 17-25 (2003)
Miyazawa, D.、Ikemoto, A.、Fujii, Y.、Okuyama, H.:“猪血小板膜中磷脂酸特异性磷脂酶 A1 的部分纯化和表征。”Biochim.Biophys.Acta.. 1631. 17-25
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Okuyama, H., Fujii, Y., Ikemoto, A.: "Brightness-Discrimination learning behavior and retinal function affected by long-term α-linolenic acie deficiency in rat."Fatty Acids : Physiological and Behavioral Functions.. 103. 418-422 (2001)
Okuyama, H.、Fujii, Y.、Ikemoto, A.:“大鼠长期 α-亚麻酸缺乏对亮度辨别学习行为和视网膜功能的影响。”脂肪酸:生理和行为功能.. 103. 418 -422 (2001)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tatematsu, K., Hirose, N., Ichikawa, Y., Fujii, Y., Takami, A., Okuyama, H.: "Nutritional Evaluation of an Inter-Esterified Perilla Oil and Lard in Comparison with Butter and Margarine Based on the Survival of Stroke-Prone Spontaneously Hypertensive(SHRSP
Tatematsu, K.、Hirose, N.、Ichikawa, Y.、Fujii, Y.、Takami, A.、Okuyama, H.:“基于酯化的紫苏油和猪油与黄油和人造黄油的比较的营养评价
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tokudome, S., Yokoyama, Y., Kamiya, T., Seno, K., Okuyama, H., Kuriki, K., Cheng, J., Nakamura, T., Fujii, T., Ichikawa, H., Itoh, M.: "Rationale and study design of dietary intervention in patients polypectomized for tumors of the colorectum."Jpn.J.Clin.
德留 S.、横山 Y.、神谷 T.、濑野 K.、奥山 H.、栗木 K.、程 J.、中村 T.、藤井 T.、市川 H.、
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OKUYAMA Harumi其他文献

OKUYAMA Harumi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OKUYAMA Harumi', 18)}}的其他基金

Mechanisms by which dietary oils affect behavioral patterns of rats
膳食油影响大鼠行为模式的机制
  • 批准号:
    09672242
  • 财政年份:
    1997
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effect of Essential Fatty Acid Balance on Symptoms in Various Models for Chronic Disorders.
必需脂肪酸平衡对各种慢性疾病模型症状的影响。
  • 批准号:
    01480494
  • 财政年份:
    1989
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Elucidation of atopic dermatitis pathology through nucleic acid-independent single-cell microbiome analysis
通过不依赖核酸的单细胞微生物组分析阐明特应性皮炎病理学
  • 批准号:
    23H02930
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of the mechanism related to dental metal allergy to exacerbation of atopic dermatitis
阐明牙科金属过敏与特应性皮炎恶化的相关机制
  • 批准号:
    23K16062
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Skin probiotics to treat atopic dermatitis
皮肤益生菌治疗特应性皮炎
  • 批准号:
    10760367
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
Investigation of Filaggrin Gene Mutations among Latinx patients with Atopic Dermatitis
拉丁裔特应性皮炎患者丝聚蛋白基因突变的调查
  • 批准号:
    10740811
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
Genetic analysis of the pathogenesis of atopic dermatitis focusing on the allergic sensitivity of NC mice.
以NC小鼠过敏敏感性为重点的特应性皮炎发病机制的遗传分析。
  • 批准号:
    23K05600
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clarification of the pathogenic mechanism of atopic dermatitis-associated brain inflammation
阐明特应性皮炎相关脑炎症的发病机制
  • 批准号:
    23KF0068
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Living systematic review and network meta-analysis of systemic immunomodulatory treatments for atopic dermatitis
特应性皮炎全身免疫调节治疗的活体系统评价和网络荟萃分析
  • 批准号:
    485092
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Operating Grants
Patient engagement in atopic dermatitis (eczema) guidelines and a model for future trustworthy, patient-centred guidelines
患者参与特应性皮炎(湿疹)指南以及未来值得信赖、以患者为中心的指南模型
  • 批准号:
    485111
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Operating Grants
Living systematic review and network meta-analysis of systemic immunomodulatory treatments for atopic dermatitis
特应性皮炎全身免疫调节治疗的活体系统评价和网络荟萃分析
  • 批准号:
    485106
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Operating Grants
Defining the role of IL-18 in atopic dermatitis
定义 IL-18 在特应性皮炎中的作用
  • 批准号:
    10681016
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了